Evidence map›Paper›PMID 34950778›Full record

ArticleJGH open : an open access journal of gastroenterology and hepatology2021

Safety and early efficacy of endoscopic sleeve gastroplasty (ESG) for obesity in a multi-ethnic Asian population in Singapore.

Ravishankar Asokkumar, Chin Hong Lim, Ai Shan Tan, Phong Ching Lee, Alvin Eng, Jeremy Tan, Gontrand Lopez-Nava, Sonali Ganguly, Jason Chang, Christopher Khor

Open access · goldAbstract read
In one paragraph

Article in JGH open : an open access journal of gastroenterology and hepatology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 3 pooled it
2.1field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 3 syntheses or guidelines pooled it, 15 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 2 countries.

Ravishankar AsokkumarDepartment of Gastroenterology and Hepatology Singapore General Hospital Singapore Singapore.ORCID https://orcid.org/0000-0003-2822-6100
Chin Hong LimDuke-NUS Graduate Medical School Singapore Singapore.
Ai Shan TanDepartment of Nutrition and Dietetics Singapore General Hospital Singapore Singapore.
Phong Ching LeeDuke-NUS Graduate Medical School Singapore Singapore.
Alvin EngDuke-NUS Graduate Medical School Singapore Singapore.
Jeremy TanDuke-NUS Graduate Medical School Singapore Singapore.
Gontrand Lopez-NavaBariatric Endoscopy Unit, HM Sanchinarro Hospital Madrid Spain.
Sonali GangulyDuke-NUS Graduate Medical School Singapore Singapore.
Jason ChangDepartment of Gastroenterology and Hepatology Singapore General Hospital Singapore Singapore.
Christopher KhorDepartment of Gastroenterology and Hepatology Singapore General Hospital Singapore Singapore.
Singapore General Hospital · SGHospital Universitario HM Sanchinarro · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUND AND

aimEndoscopic sleeve gastroplasty (ESG) is an alternative nonsurgical treatment option for obesity. However, most studies on the utility and efficacy of ESG are derived from the Western population. It is unknown if ESG elicits similar results in Asians with different fat distribution, sociocultural customs, and dietary practices. Our study aims to assess the safety and efficacy of ESG among a multi-ethnic Asian population.

methodsWe reviewed 35 patient records who underwent primary ESG for obesity at our unit. We followed a U-shaped suture pattern. Our primary outcome was to assess technical feasibility and safety. The secondary outcome was to determine the percentage total body weight loss (TBWL) at the last follow-up.

resultsThe mean ± SD age and body mass index were 43.6 ± 11.3 years and 34 ± 4.9 kg/m

conclusionESG is a safe and effective option for promoting weight loss in a multi-ethnic Asian population. ESG-induced weight loss may improve obesity-related comorbidities.

Indexed as

bariatric endoscopyendoscopic sleeve gastroplastymorbid obesityobesityoverstitchweight loss

Identifiers

PMID34950778
PMCPMC8674547
OpenAlexW4200460959

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.